Table 1.
Schematic representation of the steps of this study.
| Study phase and data set | Cancer type and subtype | Cancer samples, n | Control samples, n | Database | |||
| Selection | IST (In Silico Transcriptomics) Online | ||||||
|
|
Melanoma and normal skin | Melanoma | 208 | 147 |
|
||
| Colorectal cancer and controls | Colorectal cancer | 991 | 64 |
|
|||
| First validation round | GEO (Gene Expression Omnibus) | ||||||
|
|
Melanoma and normal skin (GDS1375 data set) | Melanoma | 45 | 25 |
|
||
| Second validation round | Oncomine | ||||||
|
|
DNA-TCGA | Melanoma | 318 | 312 |
|
||
| DNA-TCGA | Colorectal cancer | ||||||
|
|
|
Colon adenocarcinoma | 212 | 445 |
|
||
|
|
Rectal adenocarcinoma | 90 | 445 |
|
|||
|
|
Colon mucinous adenocarcinoma | 37 | 445 |
|
|||
|
|
Cecum adenocarcinoma | 65 | 445 |
|
|||
|
|
Rectal mucinous adenocarcinoma | 7 | 445 |
|
|||
|
|
Rectosigmoid adenocarcinoma | 24 | 445 |
|
|||